Profile data is unavailable for this security.
About the company
OpGen, Inc. (OpGen) is a precision medicine company that uses molecular diagnostics and informatics to combat infectious diseases. The Company, through its subsidiaries, is focused on developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information infections caused by multidrug-resistant microorganisms (MDROs). The Company’s product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, next-generation sequencing (NGS) technology and AI-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE- in vitro diagnostics (IVD)-marked polymerase chain reaction (PCR)-based severe acute respiratory syndrome (SARS)-CoV-2 test kit. The Company’s subsidiaries include Curetis GmbH and Ares Genetics GmbH.
- Revenue in USD (TTM)3.07m
- Net income in USD-26.16m
- Incorporated2001
- Employees100.00
- LocationOpGen Inc9717 Key West Avenue, Suite 100ROCKVILLE 20850United StatesUSA
- Phone+1 (301) 869-9683
- Fax+1 (301) 869-9684
- Websitehttps://opgen.com/